Inventor
BEURSKENS FRANK
NL16 patents
⚠️ This page may combine multiple inventors who share the name “BEURSKENS FRANK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENMAB HOLDING B V
6 patentsUS11512137B2Nov 29, 2022
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
GENMAB HOLDING B V10 citations83
US11396553B2Jul 26, 2022
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
GENMAB HOLDING B V8 citations83
US11034772B2Jun 15, 2021
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
GENMAB HOLDING B V7 citations81
US12577316B2Mar 17, 2026
Methods of use of anti-CD37 antibodies, monoclonal anti-CD37 antibodies
GENMAB HOLDING B V0 citations60
US12448459B2Oct 21, 2025
Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
GENMAB HOLDING B V0 citations60
US12275797B2Apr 15, 2025
Anti-CD37 antibodies and anti-CD20 antibodies, compositions and methods of use thereof
GENMAB HOLDING B V1 citations60
GENMAB BV
4 patentsUS12049512B2Jul 30, 2024
Antibody variants and uses thereof
GENMAB BV5 citations85
US11180572B2Nov 23, 2021
Dimeric protein with triple mutations
GENMAB BV12 citations83
US12338289B2Jun 24, 2025
Antibody variant combinations and uses thereof
GENMAB BV0 citations58
US12173076B2Dec 24, 2024
Polypeptide variants and uses thereof
GENMAB BV1 citations57